Vitalis | Jotup

STARWARD WHISKY INTRODUCES LIMITED EDITION 'VITALIS' TO THE U.S.

Retrieved on:

Monday, October 31, 2022

Coffee, Vitalis, Multimedia, San Francisco, Year, Thought, Nova, MASTER, Fruit, Nose, Duplication, Industry, San Francisco World Spirits Competition, Ageing, Rum, Liquor, Starward Rogue, Solera

NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Coming off an incredible year of accolades, including Most Awarded Distillery at the San Francisco World Spirits Competition; and the top honor of 'TASTE MASTER' (best of the whole competition) at 2022 World Whisky Masters, Starward Whisky is celebrating a milestone closer to home: 2022 is the 15th anniversary of the Melbourne born and bred distillery. To mark this occasion, Starward is launching its most premium single malt whisky expression to date - a special commemorative called Vitalis, available in limited quantities in the U.S. starting today.

Key Points:

To mark this occasion, Starward is launching its most premium single malt whisky expression to date - a special commemorative called Vitalis, available in limited quantities in the U.S. starting today.
Further cementing its leadership position in the category, Starward is currently the number one brand in the Australian whisky segment driving over 50% of the Australian whisky segment growth in the last 12 months.
Australian whisky itself is the fastest growing segment of the total whisky category in Australia in the last 12 months.
Vitalis is ripe and fruity, making it instantly recognizable as a Starward whisky, while also offering something more complex as it unfolds.

CryoMass Technologies Appoints Top Extractor Sales Veteran To Lead Global Sales Just Ahead Of California Product Launch

Retrieved on:

Tuesday, August 9, 2022

DENVER, Aug. 9, 2022 /PRNewswire/ -- CryoMass Technologies Inc. (the "Company" or "CryoMass") (OTCQX: CRYM) welcomes Mike Stringile to lead its worldwide sales team as it prepares to launch its first commercial installation next month in Monterey, California. Mr. Stringile brings unsurpassed cannabis industry extraction knowledge and sales experience to CryoMass.

Key Points:

DENVER, Aug. 9, 2022 /PRNewswire/ --CryoMass Technologies Inc. (the "Company"or "CryoMass") (OTCQX: CRYM) welcomes Mike Stringile to lead its worldwide sales team as it prepares to launch its first commercial installation next month in Monterey, California.
Mr. Stringile brings unsurpassed cannabis industry extraction knowledge and sales experience to CryoMass.
When I understood what these guys were up to, I immediately thought of just one thing this will change everything!
In November 2018, Mr. Stringile joined an upstart C02 extraction company based in Kelowna, British Columbia, called Vitalis Extraction Technologies.

Vitalis Analgesics Announces Publication of Pilot Study Evaluating A Novel Oral Ketamine and Aspirin Formulation for Acute Musculoskeletal Pain

Retrieved on:

Thursday, May 26, 2022

Department, Patient, Research, Pain management, Maimonides Medical Center, Pain, VTS, Quality of life, Emergency medicine, Vitalis, Lists of diseases, Analgesic, Ketamine, Pharmaceutical industry

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Vitalis Analgesics LLC, a specialty pharmaceutical company leveraging its innovative VTS platform to overcome the limitations of existing drugs, today announced the publication of positive results from a pilot study of a novel oral ketamine and aspirin combination in acute musculoskeletal pain. The study was published online in the Journal of Emergency Medicine.

Key Points:

If proven in larger controlled trials, this could represent a breakthrough in the treatment of acute pain and a range of other indications.
Additional information, including a detailed description of the study design, eligibility criteria, and investigator sites, is available atClinicalTrials.gov using identifier NCT04702555 .
Vitalis Analgesics was spun out of Vitalis Pharmaceuticals to help unlock ketamines enormous potential as an oral medication in pain, mood disorders, and more.
An oral ketamine with favorable side effect and pharmacokinetic profiles may be a breakthrough, opening up life changing treatments for many patients.

Helen of Troy Announces Divestiture of Mass Market Personal Care Business

Retrieved on:

Tuesday, June 8, 2021

Cosmetics, Retail, Other Retail, Helen of Troy Limited, Personal hygiene products, Consumer goods, Pert Plus, Vitalis, Brut, Rexona, Cantor Fitzgerald, Brands

Proceeds from the sale announced today represent substantially all of the negotiated value for the total global Personal Care business.

Key Points:

Proceeds from the sale announced today represent substantially all of the negotiated value for the total global Personal Care business.
The Personal Care portfolio includes iconic brands such as Brut, Pert Plus, Sure, Infusium, and Vitalis.
Cantor Fitzgerald provided lead advisory services and Baker & McKenzie LLP served as legal counsel to Helen of Troy on the transaction.
All trademarks herein belong to Helen of Troy Limited (or its affiliates) and/or are used under license from their respective licensors.

ACON Investments Acquires Vitalis Group

Retrieved on:

Tuesday, June 1, 2021

Vitalis, ACON Investments, Acon, Winston & Strawn

and its affiliates ("ACON"), announced today that ACON Latin America Opportunities Fund V, L.P. (the "Fund") in partnership with some of its Limited Partners as co-investors, completed, on May 27, 2021, the acquisitions of the companies that form the Vitalis Group ("Vitalis") a leading manufacturer and wholesaler of generic injectable pharmaceuticals with production facilities in Colombia and Mexico, with sales to more than 20 countries, mainly in Latin America.

Key Points:

and its affiliates ("ACON"), announced today that ACON Latin America Opportunities Fund V, L.P. (the "Fund") in partnership with some of its Limited Partners as co-investors, completed, on May 27, 2021, the acquisitions of the companies that form the Vitalis Group ("Vitalis") a leading manufacturer and wholesaler of generic injectable pharmaceuticals with production facilities in Colombia and Mexico, with sales to more than 20 countries, mainly in Latin America.
ACON believes that Vitalis offers a unique platform to grow and cross-sell its more than 700 pharmaceutical products to multiple countries across Latin America.
As part of the transaction, ACON recruited Esteban Lizarazo as CEO of Vitalis.
advised Vitalis' shareholders while Grant Thornton LLP, Winston & Strawn LLP, Gmez-Pinzn Abogados S.A.S., and Mijares, Angoitia, Corts y Fuentes, S.C. advised ACON.

Vitalis Extraction Technology Adds Cosolvent Injection System to Its Premium Fleet of Extraction Solutions

Retrieved on:

Tuesday, March 9, 2021

Cosolvent, Solvents, Vitalis, Kelowna, Extraction

KELOWNA, BC, March 9, 2021 /PRNewswire/ --The global leader in CO2 extraction solutions, Vitalis Extraction Technology, Inc. ( Vitalis ) today announces the introduction of its latest innovation, the Cosolvent Injection System (CIS).

Key Points:

KELOWNA, BC, March 9, 2021 /PRNewswire/ --The global leader in CO2 extraction solutions, Vitalis Extraction Technology, Inc. ( Vitalis ) today announces the introduction of its latest innovation, the Cosolvent Injection System (CIS).
As Vitalis CEO, Joel Sherlock, explains the Vitalis CIS has been designed to help companies scale their operations, by reducing their cost per gram.
"From the beginning, our innovation has been led by customer collaboration, and the launch of Vitalis CIS is no exception.
Vitalis Extraction Technology Inc. (Vitalis) is a privately-owned, Kelowna BC-based engineering and manufacturing company, producing industrial supercritical CO2 extraction solutions for the cannabis, hemp, pharmaceuticals, F&B and essential oil industries.

Vitalis Extraction Technology Adds Cosolvent Injection System to Its Premium Fleet of Extraction Solutions

Retrieved on:

Tuesday, March 9, 2021

Cosolvent, Solvents, Vitalis, Kelowna, Extraction

KELOWNA, BC, March 9, 2021 /PRNewswire/ --The global leader in CO2 extraction solutions, Vitalis Extraction Technology, Inc. ( Vitalis ) today announces the introduction of its latest innovation, the Cosolvent Injection System (CIS).

Key Points:

KELOWNA, BC, March 9, 2021 /PRNewswire/ --The global leader in CO2 extraction solutions, Vitalis Extraction Technology, Inc. ( Vitalis ) today announces the introduction of its latest innovation, the Cosolvent Injection System (CIS).
As Vitalis CEO, Joel Sherlock, explains the Vitalis CIS has been designed to help companies scale their operations, by reducing their cost per gram.
"From the beginning, our innovation has been led by customer collaboration, and the launch of Vitalis CIS is no exception.
Vitalis Extraction Technology Inc. (Vitalis) is a privately-owned, Kelowna BC-based engineering and manufacturing company, producing industrial supercritical CO2 extraction solutions for the cannabis, hemp, pharmaceuticals, F&B and essential oil industries.

Vitalis Extraction Technology Prioritizes Efficiency and Innovation With Appointment of Joel Sherlock to CEO

Retrieved on:

Thursday, December 3, 2020

Vitalis, Extraction, Cannabis, Hemp, Draft:Vitalis Extraction Technology

KELOWNA,BC, Dec. 3, 2020 /PRNewswire/ -- Vitalis Extraction Technology, Inc. ( Vitalis ) is pleased to announce the promotion of Chairman and Co-founder, Joel Sherlock, to the position of CEO.

Key Points:

KELOWNA,BC, Dec. 3, 2020 /PRNewswire/ -- Vitalis Extraction Technology, Inc. ( Vitalis ) is pleased to announce the promotion of Chairman and Co-founder, Joel Sherlock, to the position of CEO.
Looking to the future, Vitalis's newly-appointed CEO, reveals realignment plans to foster greater efficiency and more agile decision-making across its workforce.
Newly appointed CEO, Joel Sherlock is one of three synergistic and unique Co-founders who represent the driving forces of the company.
Vitalis Extraction Technology Inc. (Vitalis) is a privately-owned, Kelowna BC -based engineering and manufacturing company, producing industrial supercritical CO2 extraction systems for the cannabis, hemp, pharmaceuticals, F&B and essential oil industries.